These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24439439)

  • 1. Long-term follow-up of tacrolimus ointment for treatment of atopic keratoconjunctivitis.
    Al-Amri AM
    Am J Ophthalmol; 2014 Feb; 157(2):280-6. PubMed ID: 24439439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrolimus Ointment for Treatment of Vernal Keratoconjunctivitis.
    Al-Amri AM; Mirza AG; Al-Hakami AM
    Middle East Afr J Ophthalmol; 2016; 23(1):135-8. PubMed ID: 26957853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical calcineurin inhibitors in the treatment of steroid-dependent atopic keratoconjunctivitis.
    Tzu JH; Utine CA; Stern ME; Akpek EK
    Cornea; 2012 Jun; 31(6):649-54. PubMed ID: 22378107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical tacrolimus 0.03% ointment for intractable allergic conjunctivitis: an open-label pilot study.
    Attas-Fox L; Barkana Y; Iskhakov V; Rayvich S; Gerber Y; Morad Y; Avni I; Zadok D
    Curr Eye Res; 2008 Jul; 33(7):545-9. PubMed ID: 18600486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of refractory atopic blepharoconjunctivitis with topical tacrolimus 0.03% dermatologic ointment.
    Sakarya Y; Sakarya R
    J Ocul Pharmacol Ther; 2012 Feb; 28(1):94-6. PubMed ID: 22103968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of tacrolimus ointment for refractory ocular surface inflammatory diseases.
    Miyazaki D; Tominaga T; Kakimaru-Hasegawa A; Nagata Y; Hasegawa J; Inoue Y
    Ophthalmology; 2008 Jun; 115(6):988-992.e5. PubMed ID: 17900694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term result of maintenance treatment with tacrolimus ointment in chronic ocular graft-versus-host disease.
    Jung JW; Lee YJ; Yoon SC; Kim TI; Kim EK; Seo KY
    Am J Ophthalmol; 2015 Mar; 159(3):519-27.e1. PubMed ID: 25498356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 0.03% tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis: a retrospective study.
    Virtanen HM; Reitamo S; Kari M; Kari O
    Acta Ophthalmol Scand; 2006 Oct; 84(5):693-5. PubMed ID: 16965503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic tacrolimus in the treatment of severe atopic keratoconjunctivitis.
    Stumpf T; Luqmani N; Sumich P; Cook S; Tole D
    Cornea; 2006 Dec; 25(10):1147-9. PubMed ID: 17172887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus ointment vs steroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis.
    Nivenius E; van der Ploeg I; Jung K; Chryssanthou E; van Hage M; Montan PG
    Eye (Lond); 2007 Jul; 21(7):968-75. PubMed ID: 16680103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of systemic T-lymphocyte signal transduction inhibitors in the treatment of atopic keratoconjunctivitis.
    Anzaar F; Gallagher MJ; Bhat P; Arif M; Farooqui S; Foster CS
    Cornea; 2008 Sep; 27(8):884-8. PubMed ID: 18724148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical tacrolimus ointment for treatment of intractable atopic keratoconjunctivitis: a case report and review of the literature.
    García DP; Alperte JI; Cristóbal JA; Mateo Orobia AJ; Muro EM; Valyi Z; Del Rio BJ; Arnao MR
    Cornea; 2011 Apr; 30(4):462-5. PubMed ID: 20861732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus in Corticosteroid-Refractory Vernal Keratoconjunctivitis.
    Chatterjee S; Agrawal D
    Cornea; 2016 Nov; 35(11):1444-1448. PubMed ID: 27310883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatologic tacrolimus ointment on the eyelids for steroid-refractory vernal keratoconjunctivitis.
    Liu FY; Liu HY; Chu HS; Chen WL; Hu FR; Wang IJ
    Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):967-974. PubMed ID: 30852635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of 0.1% tacrolimus ophthalmic suspension in the treatment of severe atopic keratoconjunctivitis.
    Yazu H; Shimizu E; Aketa N; Dogru M; Okada N; Fukagawa K; Fujishima H
    Ann Allergy Asthma Immunol; 2019 Apr; 122(4):387-392.e1. PubMed ID: 30639466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
    Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL;
    Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders.
    Joseph MA; Kaufman HE; Insler M
    Cornea; 2005 May; 24(4):417-20. PubMed ID: 15829797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atopic dermatitis management with tacrolimus ointment (Protopic).
    Kapp A; Allen BR; Reitamo S
    J Dermatolog Treat; 2003; 14(Suppl 1):5-16. PubMed ID: 14522634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
    Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.
    Singalavanija S; Noppakun N; Limpongsanuruk W; Wisuthsarewong W; Aunhachoke K; Chunharas A; Wananukul S; Akaraphanth R
    J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.